March 2, 2026- Thermo Fisher Scientific announced the launch of Thermo Scientific™ Brilliance™ Candida 2 Agar and Spectra™ Candida Agar, new color-based (chromogenic) culture media to help laboratories quickly detect and differentiate clinically important Candida species — including Candida auris, a growing global antimicrobial resistance (AMR) threat.
Invasive fungal infections are an increasing challenge for healthcare systems worldwide, driven in part by the rapid spread of Candida auris. This pathogen is often resistant to multiple antifungal treatments, can spread quickly in healthcare settings and is associated with serious illness and high mortality rates. As screening and surveillance efforts expand, clinical microbiology laboratories need faster, reliable tools to identify infections and support infection prevention and control.
